For research scientists, there are now numerous molecular targets for antiobesity drugs: central receptors for biogenic amines, cannabinoids, hypothalamic neuropeptides, peripheral β3-adrenoceptor, and UCPs; and dominating all obesity research is leptin—a tantalizing but frustrating obesity target. This evidence concerns the gene LEP and obesity disorder.